We are live on
!
Find out more
TC
TFS Capital Portfolio holdings
AUM
$255M
1-Year Est. Return
32.31%
This Fund
S&P 500
This Quarter
Est. Return
+8.8%
1 Year Est. Return
+32.31%
3 Year Est. Return
+53.79%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$374M
AUM Growth
-$43.6M
(-10%)
Cap. Flow
-$66M
Cap. Flow
% of AUM
-17.63%
Top 10 Holdings %
Top 10 Hldgs %
5.06%
Holding
1,045
New
320
Increased
158
Reduced
228
Closed
333
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MacroGenics
MGNX
|
+$1.88M |
| 2 |
OSG
Overseas Shipholding Group Inc.
OSG
|
+$1.69M |
| 3 |
CHMT
Chemtura Corporation
CHMT
|
+$1.67M |
| 4 |
INST
Instructure, Inc.
INST
|
+$1.65M |
| 5 |
RP
RealPage, Inc.
RP
|
+$1.57M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LTRPA
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
|
+$2.15M |
| 2 |
ICU Medical
ICUI
|
+$2.15M |
| 3 |
Skywest
SKYW
|
+$2.06M |
| 4 |
NAVG
Navigators Group Inc
NAVG
|
+$2.01M |
| 5 |
Insight Enterprises
NSIT
|
+$2.01M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.93% |
| 2 | Consumer Discretionary | 14.92% |
| 3 | Industrials | 12.56% |
| 4 | Technology | 10.41% |
| 5 | Financials | 8.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KYNB
26
Kyntra Bio
KYNB
$28.5M
| $1.59M | 0.43% |
2,975
-607
| -17% | -$303K |
|
|
GHDX
27
DELISTED
Genomic Health, Inc.
GHDX
| $1.59M | 0.42% |
54,058
-11,028
| -17% | -$336K |
|
|
UAM
28
DELISTED
Universal American Corp
UAM
| $1.57M | 0.42% |
+158,044
| New | +$1.39M |
|
|
SCLN
29
DELISTED
Sciclone Pharmaceuticals Inc
SCLN
| $1.56M | 0.42% |
144,575
+19,985
| +16% | +$200K |
|
|
ODP
30
DELISTED
ODP
ODP
| $1.56M | 0.42% |
34,416
-15,453
| -31% | -$640K |
|
31
Addus HomeCare
ADUS
$2.14B
| $1.55M | 0.41% |
+44,292
| New | +$1.37M |
|
32
Scansource
SCSC
$1.12B
| $1.55M | 0.41% |
+38,415
| New | +$1.43M |
|
33
Entegris
ENTG
$19.7B
| $1.55M | 0.41% |
86,562
+37,982
| +78% | +$659K |
|
34
Semtech
SMTC
$11.7B
| $1.55M | 0.41% |
+49,109
| New | +$1.38M |
|
35
Barrett Business Services
BBSI
$976M
| $1.54M | 0.41% |
+96,404
| New | +$1.3M |
|
36
Telephone and Data Systems
TDS
$3.91B
| $1.54M | 0.41% |
53,296
-6,139
| -10% | -$167K |
|
37
Avanos Medical
AVNS
$1.17B
| $1.54M | 0.41% |
41,544
-9,142
| -18% | -$327K |
|
|
CTLT
38
DELISTED
CATALENT, INC.
CTLT
| $1.53M | 0.41% |
56,818
-2,287
| -4% | -$56.7K |
|
|
39
MacroGenics
MGNX
$235M
| $1.53M | 0.41% |
+74,801
| New | +$1.88M |
|
40
Andersons Inc
ANDE
$2.65B
| $1.51M | 0.4% |
+33,780
| New | +$1.32M |
|
41
Scholastic
SCHL
$796M
| $1.51M | 0.4% |
+31,767
| New | +$1.35M |
|
|
PGNX
42
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $1.51M | 0.4% |
+174,408
| New | +$1.29M |
|
|
CALY
43
Callaway Golf Company
CALY
$3.26B
| $1.5M | 0.4% |
137,032
-59,092
| -30% | -$670K |
|
|
INST
44
DELISTED
Instructure, Inc.
INST
| $1.5M | 0.4% |
+76,822
| New | +$1.65M |
|
|
NTUS
45
DELISTED
Natus Medical Inc
NTUS
| $1.49M | 0.4% |
42,828
+1,999
| +5% | +$78.5K |
|
46
Commault Systems
CVLT
$5.89B
| $1.49M | 0.4% |
28,956
+19,476
| +205% | +$1.04M |
|
|
MTOR
47
DELISTED
MERITOR, Inc.
MTOR
| $1.48M | 0.4% |
119,396
+100,001
| +516% | +$1.18M |
|
|
IPXL
48
DELISTED
Impax Laboratories, Inc.
IPXL
| $1.48M | 0.4% |
111,941
+42,051
| +60% | +$719K |
|
|
HRC
49
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $1.48M | 0.4% |
26,362
+493
| +2% | +$28K |
|
50
Coherus Oncology
CHRS
$217M
| $1.48M | 0.4% |
52,513
+43,480
| +481% | +$1.22M |
|
Similar funds
KC
IPC
ECPI
FRM
WFG
IFB
KL
RP
TFS Capital's Q4 2016 Portfolio in Review
As of Q4 2016, TFS Capital held 1,045 positions worth $374M, down 10% from $418M the previous quarter. Its ten largest holdings account for 5.1% of the portfolio.
TFS Capital withdrew a net $66M in Q4 2016, closing 333 positions and reducing 228 holdings. Its most notable exit was Liberty TripAdvisor Holdings, Inc. Series A, an estimated $2.15M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Industrials.
Against the trend, TFS Capital opened a new position in MacroGenics worth $1.53M.
- TFS Capital's largest Q4 2016 buy was MacroGenics: 74,801 shares worth $1.53M.
- TFS Capital added most to Overseas Shipholding Group Inc. in Q4 2016, an estimated $1.69M increase.
- TFS Capital's biggest Q4 2016 reduction was ICU Medical, cutting an estimated $2.15M.
- TFS Capital fully exited Liberty TripAdvisor Holdings, Inc. Series A in Q4 2016, selling an estimated $2.15M.
- TFS Capital's ten largest holdings make up 5.1% of its $374M portfolio in Q4 2016.
- TFS Capital opened 320 new positions and closed 333 in Q4 2016.
- TFS Capital's portfolio value fell 10% quarter-over-quarter to $374M.
Based on TFS Capital's 13F filing for Q4 2016, filed 20 Jan 2017.